AMEDISYS, INC. |
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
| 91.02 USD | +0.06% |
|
-1.22% | -4.12% |
Financials (USD)
| Sales 2024 * | 2.34B | Sales 2025 * | 2.5B | Capitalization | 2.97B |
|---|---|---|---|---|---|
| Net income 2024 * | 144M | Net income 2025 * | 155M | EV / Sales 2024 * | 1.4 x |
| Net Debt 2024 * | 305M | Net Debt 2025 * | 311M | EV / Sales 2025 * | 1.31 x |
| P/E ratio 2024 * |
20.9
x | P/E ratio 2025 * |
19.5
x | Employees | 19,000 |
| Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 83.73% |
More Fundamentals
* Assessed data
More news
More recommendations
| 1 day | -0.32% | ||
| 1 week | -1.42% | ||
| Current month | -1.30% | ||
| 1 month | -2.41% | ||
| 3 months | -3.94% | ||
| 6 months | -2.34% | ||
| Current year | -4.31% |
1 week
90.77
92.51
1 month
90.1093.92
Current year
90.1095.59
1 year
73.1096.44
3 years
69.37292.97
5 years
69.37325.12
10 years
12.86325.12
| Managers | Title | Age | Since |
|---|---|---|---|
| Chief Executive Officer | 49 | 23-04-09 | |
Scott Ginn
DFI | Director of Finance/CFO | 55 | 17-01-31 |
Paul Kusserow
CHM | Chairman | 62 | 14-12-15 |
| Members of the board | Title | Age | Since |
|---|---|---|---|
| Director/Board Member | 70 | 15-04-21 | |
Molly Joel Coye
BRD | Director/Board Member | 76 | 19-10-31 |
Vickie Capps
BRD | Director/Board Member | 62 | 19-10-31 |
| Name | Weight | AuM | 1st Jan change | Investor Rating |
|---|---|---|---|---|
| 1.18% | 8 M€ | -.--% | ||
| 0.83% | 2 M€ | +6.54% | ||
| 0.24% | 509 M€ | -.--% | ||
| 0.17% | 45 M€ | -2.85% |
| Date | Price | Change | Volume |
|---|---|---|---|
| 24-04-18 | 91.14 | +0.20% | 96 280 |
| 24-04-17 | 90.96 | -0.32% | 307,074 |
| 24-04-16 | 91.25 | -0.11% | 403,661 |
| 24-04-15 | 91.35 | -0.60% | 214,364 |
| 24-04-12 | 91.9 | -0.40% | 157,142 |
Delayed Quote Nasdaq, April 17, 2024 at 04:00 pm EDT
More quotes
Amedisys, Inc. is a healthcare service company. The Company is engaged in providing care and support in the home. It delivers clinically distinct care that suits its patients' needs, whether that is home-based recovery and rehabilitation after an operation or injury or care. Its operations involve serving patients across the United States through its three operating divisions: home health, hospice, and high acuity care. Its home health segment provides compassionate healthcare to help its patients recover from surgery or illness, live with chronic diseases, and prevent avoidable hospital readmissions. The home health includes 346 care centers located in 34 states within the United States and the District of Columbia. Its hospice care is designed to provide comfort and support for those who are dealing with a terminal illness. Its high acuity care segment delivers the essential elements of inpatient hospital, skilled nursing facility care and palliative care to patients in their homes.
Calendar
2024-04-30
- Q1 2024 Earnings Release (Projected)
Trading Rating
Investor Rating
ESG Refinitiv
B-
Sell
Buy
Mean consensus
HOLD
Number of Analysts
10
Last Close Price
90.96
USD
Average target price
97.78
USD
Spread / Average Target
+7.50%
EPS Revisions
| 1st Jan change | Capi. | |
|---|---|---|
| -4.31% | 2.97B | |
| 0.00% | 1.76B | |
| +4.06% | 1.55B | |
| +43.75% | 601M | |
| -1.84% | 510M | |
| -39.89% | 350M | |
| -13.74% | 135M | |
| -39.85% | 124M | |
| +3.85% | 71.51M |
- Stock Market
- Equities
- AMED Stock
